utritional Aspects in Head and Neck Cancer Patients undergoing Radio(chemo)therapy

Not Applicable

Recruiting

• Conditions: C00-C14; R64; Malignant neoplasms of lip, oral cavity and pharynx; Cachexia

• Registration Number: DRKS00016862
• Lead Sponsor: Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients who undergo curative radio(chemo)therapy at the Department of Radiotherapy and Radiooncology of the University Medical Center Hamburg-Eppendorf (and/or its outpatient center) due to head and neck cancer
- Patients who are at least 18 years old

Exclusion Criteria

- Pregnancy
- Patients who are not able sign written informed consent
- Patients with a cardiac defibrillator

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary endpoints include the assessment of phase angle from bioelectric impedance measurements as an indicator for malnutrition. Also, we want to examine whether there is a difference in phase angle between our control and our interventional group.

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints include therapy-related toxicity, thus implying that patients undergoing an intensified dietary and nutritional counseling present with less therapy-related side effects (according to CTCAE-criteria). Also, assessment of quality of life in both groups (control and interventional group) and outcome factors including survival rates are to be examined.